IL17A and chronic obstructive pulmonary disease: Conversely, in osteoporosis induced by chronic obstructive pulmonary disease (COPD) and parathyroid hormone (PTH), a deficiency in IL-17A reduces bone loss by decreasing osteoclast activity and RANKL expression (96, 97).